Management of Widespread Fungal Infection with Elevated SGPT
Initial Antifungal Selection Based on Liver Function
- The Infectious Diseases Society of America recommends using an echinocandin (caspofungin, micafungin, or anidulafungin) as first-line therapy for patients with widespread fungal infection and significantly elevated SGPT, due to the hepatotoxicity risk with azoles in the setting of existing liver dysfunction 1, 2
- Echinocandins are the optimal choice when liver transaminases are already elevated, as they have minimal hepatotoxicity compared to azoles, with specific dosing recommendations: Caspofungin (70 mg loading dose, then 50 mg daily), Micafungin (100 mg daily), and Anidulafungin (200 mg loading dose, then 100 mg daily) 1
- Lipid formulation amphotericin B (3-5 mg/kg daily) is an alternative if echinocandins cannot be used, though it carries nephrotoxicity risk 1, 2
Essential Diagnostic Steps
- Obtain blood cultures and cultures from all potentially infected sites immediately, and request antifungal susceptibility testing on all isolates to guide definitive therapy 1, 3, 4
- Perform imaging (CT or ultrasound) of liver, spleen, and genitourinary tract if blood cultures remain positive 1, 3
Source Control Measures
- Remove central venous catheters as soon as medically feasible, as this is strongly recommended for candidemia 1, 3
- Provide surgical drainage or debridement for any identified abscesses or necrotic tissue 1
Treatment Duration
- Continue antifungal therapy for a minimum of 2 weeks after documented clearance of fungus from bloodstream and resolution of symptoms 1, 3, 4
- Extend duration if metastatic complications develop (endophthalmitis, endocarditis, osteomyelitis) - these require 4-6 weeks or longer 1, 5
Transition to Azole Therapy
- Once liver enzymes normalize and the patient is clinically stable with documented bloodstream clearance, step-down to fluconazole 400 mg (6 mg/kg) daily is reasonable for fluconazole-susceptible isolates 1, 2